Measure | 2017–18, n (%) | 2018–19, n (%) | ||||||
---|---|---|---|---|---|---|---|---|
Full sample | Females only | Males only | χ2, t (p) | Full sample | Females only | Males only | χ2, t (p) | |
Physical activity | ||||||||
 Daily MVPA minutes, mean (SD) | 107.9 (78.6) | 98.5 (72.0) | 118.7 (84.2) | −19.6 (< 0.0001) | 101.9 (77.4) | 91.8 (70.1) | 113.7 (83.6) | −12.8 (< 0.0001) |
 Meets MVPA guidelines | 9300 (39.8) | 4129 (33.0) | 5171 (47.5) | 507.1 (< 0.0001) | 8888 (37.0) | 3926 (30.3) | 4962 (44.9) | 540.0 (< 0.0001) |
 Does not meet MVPA guidelines | 14,095 (60.2) | 8373 (67.0) | 5722 (52.5) | 15,119 (63.0) | 9019 (69.7) | 6100 (55.1) | ||
Anxiety symptoms | ||||||||
 GAD-7 score, mean (SD) | 5.9 (5.4) | 7.3 (5.7) | 4.3 (4.6) | 44.4 (< 0.0001) | 6.5 (5.6) | 8.0 (5.7) | 4.8 (4.9) | 47.5 (< 0.0001) |
 GAD-7 score ≥ 10 | 5150 (22.0) | 3786 (30.3) | 1364 (12.5) | 1069.7 (< 0.0001) | 6189 (25.8) | 4482 (34.6) | 1707 (15.4) | 1148.3 (< 0.0001) |
 GAD-7 score < 10 | 18,245 (78.0) | 8716 (69.7) | 9529 (87.5) | 17,818 (74.2) | 8463 (65.4) | 9355 (84.6) | ||
Depression symptoms | ||||||||
 CESD-R-10 score, mean (SD) | 8.1 (5.8) | 9.3 (6.2) | 6.8 (4.9) | 33.4 (< 0.0001) | 9.0 (6.0) | 10.2 (6.3) | 7.5 (5.4) | 35.8 (< 0.0001) |
 CESD-R-10 score ≥ 10 | 7470 (31.9) | 5024 (40.2) | 2446 (22.5) | 842.0 (< 0.0001) | 9241 (38.5) | 6180 (47.7) | 3061 (27.7) | 1014.7 (< 0.0001) |
 CESD-R-10 score < 10 | 15,925 (68.1) | 7478 (59.8) | 8447 (77.5) | 14,766 (61.5) | 6765 (52.3) | 8001 (72.3) |